Status:
UNKNOWN
Transplantation of Acellular Corneal Matrix to Treat Corneal Ulcer
Lead Sponsor:
Shaanxi Aierfu Activtissue Engineering
Collaborating Sponsors:
Shenzhen AiNear Cornea Engineering Company Limited
Air Force Military Medical University, China
Conditions:
Corneal Ulcer
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
This study is to develop a lamellar keratoplasty method for corneal ulcer using acellular corneal matrix (ACM) and to make an analysis among patients for its therapeutic effect.
Detailed Description
Infections, chemical injury, and other diseases result in acute or chronic corneal ulcer, which may damage corneal stroma and may lead to permanent corneal scars and blindness. Corneal transplantation...
Eligibility Criteria
Inclusion
- Patients aged between 18 and 75 yrs.
- Corneal ulcer.
- Informed consent.
Exclusion
- Corneal perforation.
- Other ocular diseases.
- The presence of systemic connective tissue diseases
- Severe allergic constitution
- Pregnancy
- The presence of chronic disease, such as significant cardiovascular illness
- The patients who received clinical experiments for other medicine or medical devices within 3 months prior to the transplantation.
- Any patient that is not suitable for recruitment, in the judgment of the investigator.
Key Trial Info
Start Date :
April 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2012
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01244776
Start Date
April 1 2010
End Date
July 1 2012
Last Update
May 6 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Tongren Hospital
Beijing, Beijing Municipality, China, 100730